10-K Decoder · All companies

Arcturus Therapeutics Holdings Inc.

ARCT · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$82.0M$152M−46.1%
Operating income−$76.3M−$95.7M+20.3%
Net income−$65.8M−$80.9M+18.7%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026

$Q3 2026Year earlierChange
Revenue$18.3M$17.2M+6.4%
Operating income−$9.20M−$16.5M+44.2%
Net income−$7.40M−$13.4M+44.8%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Arcturus's revenue in FY2025?
$82.0M in FY2025 (Fiscal year ended Dec 31, 2025), −46.1% vs $152M a year earlier, per its 10-K filed Mar 2026.
Was Arcturus profitable in FY2025?
No: net income was −$65.8M and operating income −$76.3M in FY2025.
What was Arcturus's revenue in Q3 2026?
$18.3M (+6.4% vs a year earlier), per its Form 10-Q filed Nov 5, 2026.